|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received on August 31, 2005
Accepted on May 4, 2006
Lipids, Lipoproteins, and Cardiovascular Risk Factors |
1 Naval Health Research Center, San Diego, CA
2 Kronos Science Laboratories, Inc., Phoenix, AZ
* To whom correspondence should be addressed. E-mail: chris.heward{at}kronoslaboratory.com.
Background: Our study seeks to clarify the extent of differences in analytical results, from a clinical perspective, among 4 leading technologies currently used in clinical reference laboratories for the analysis of LDL subfractions: gradient gel electrophoresis (GGE), ultracentrifugation-vertical auto profile (VAP), nuclear magnetic resonance (NMR), and tube gel electrophoresis (TGE).
Methods: We collected 4 simultaneous blood samples from 40 persons (30 males and 10 females) to determine LDL subclasses in 4 different clinical reference laboratories using different methods for analysis. LDL subfractions were assessed according to LDL particle size and the results categorized according to LDL phenotype. We compared results obtained from the different technologies.
Results: We observed substantial heterogeneity of results and interpretations among the 4 methods. Complete agreement among methods with respect to LDL subclass phenotyping occurred in only 8% (n = 3) of the persons studied. NMR and GGE agreed most frequently at 70% (n = 28), whereas VAP matched least often.
Conclusions: As measurement of LDL subclasses becomes increasingly popular, standardization of methodologies is needed. Variation among currently available methods renders them unreliable and limits their clinical usefulness.
The following articles in journals at HighWire Press have cited this article:
![]() |
H. R. Superko Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful Circulation, May 5, 2009; 119(17): 2383 - 2395. [Full Text] [PDF] |
||||
![]() |
S. Mora Advanced Lipoprotein Testing and Subfractionation Are Not (Yet) Ready for Routine Clinical Use Circulation, May 5, 2009; 119(17): 2396 - 2404. [Full Text] [PDF] |
||||
![]() |
S. Ip, A. H. Lichtenstein, M. Chung, J. Lau, and E. M. Balk Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes Ann Intern Med, April 7, 2009; 150(7): 474 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Mudd, B. A. Borlaug, P. V. Johnston, B. G. Kral, R. Rouf, R. S. Blumenthal, and P. O. Kwiterovich Jr Beyond Low-Density Lipoprotein Cholesterol: Defining the Role of Low-Density Lipoprotein Heterogeneity in Coronary Artery Disease J. Am. Coll. Cardiol., October 30, 2007; 50(18): 1735 - 1741. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Teerlink and P. G. Scheffer LDL Particles Are Nonspherical: Consequences for Size Determination and Phenotypic Classification Clin. Chem., February 1, 2007; 53(2): 361 - 362. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |